POLIVY

Powder for concentrate for solution for infusion, 140mg
RxActive license

Active substance (INN)

polatuzumab vedotin

Pharmaceutical form

Pharmaceutical formPowder for concentrate for solution for infusion
Strength140mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerF.Hoffmann-La Roche Ltd., Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01XC37)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateAugust 23, 2022

Analogs in Montenegro

1

Other medicines with the same active substance

POLIVYRx
Powder for concentrate for solution for infusion, 30mgF.Hoffmann-La Roche Ltd.
Source: CInMED register